441 related articles for article (PubMed ID: 28384752)
41. Increased levels of MIP-1α in CSF and serum of ALS.
Yang X; Gao L; Wu X; Zhang Y; Zang D
Acta Neurol Scand; 2016 Aug; 134(2):94-100. PubMed ID: 26427609
[TBL] [Abstract][Full Text] [Related]
42. Exploratory double-blind, parallel-group, placebo-controlled study of edaravone (MCI-186) in amyotrophic lateral sclerosis (Japan ALS severity classification: Grade 3, requiring assistance for eating, excretion or ambulation).
WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 18 STUDY GROUP
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Oct; 18(sup1):40-48. PubMed ID: 28872915
[TBL] [Abstract][Full Text] [Related]
43. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
44. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.
Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P
JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479
[TBL] [Abstract][Full Text] [Related]
45. Increased serum ferritin levels in amyotrophic lateral sclerosis (ALS) patients.
Goodall EF; Haque MS; Morrison KE
J Neurol; 2008 Nov; 255(11):1652-6. PubMed ID: 18677636
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis.
Scarafino A; D'Errico E; Introna A; Fraddosio A; Distaso E; Tempesta I; Morea A; Mastronardi A; Leante R; Ruggieri M; Mastrapasqua M; Simone IL
J Neurol; 2018 Oct; 265(10):2353-2362. PubMed ID: 30116940
[TBL] [Abstract][Full Text] [Related]
47. Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes.
Zhao W; Beers DR; Hooten KG; Sieglaff DH; Zhang A; Kalyana-Sundaram S; Traini CM; Halsey WS; Hughes AM; Sathe GM; Livi GP; Fan GH; Appel SH
JAMA Neurol; 2017 Jun; 74(6):677-685. PubMed ID: 28437540
[TBL] [Abstract][Full Text] [Related]
48. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?
de Carvalho M; Swash M
Arch Neurol; 2006 Apr; 63(4):557-60. PubMed ID: 16606769
[TBL] [Abstract][Full Text] [Related]
49. The Role of APOE in the Occurrence of Frontotemporal Dementia in Amyotrophic Lateral Sclerosis.
Chiò A; Brunetti M; Barberis M; Iazzolino B; Montuschi A; Ilardi A; Cammarosano S; Canosa A; Moglia C; Calvo A
JAMA Neurol; 2016 Apr; 73(4):425-30. PubMed ID: 26903389
[TBL] [Abstract][Full Text] [Related]
50. Urinary p75
Shepheard SR; Wuu J; Cardoso M; Wiklendt L; Dinning PG; Chataway T; Schultz D; Benatar M; Rogers ML
Neurology; 2017 Mar; 88(12):1137-1143. PubMed ID: 28228570
[TBL] [Abstract][Full Text] [Related]
51. Exploratory double-blind, parallel-group, placebo-controlled extension study of edaravone (MCI-186) in amyotrophic lateral sclerosis.
WRITING GROUP ON BEHALF OF THE EDARAVONE (MCI-186) ALS 17 STUDY GROUP
Amyotroph Lateral Scler Frontotemporal Degener; 2017 Oct; 18(sup1):20-31. PubMed ID: 28872918
[TBL] [Abstract][Full Text] [Related]
52. Rate of disease progression: a prognostic biomarker in ALS.
Labra J; Menon P; Byth K; Morrison S; Vucic S
J Neurol Neurosurg Psychiatry; 2016 Jun; 87(6):628-32. PubMed ID: 26152368
[TBL] [Abstract][Full Text] [Related]
53. Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis.
Lanznaster D; Bejan-Angoulvant T; Patin F; Andres CR; Vourc'h P; Corcia P; Blasco H
Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):199-206. PubMed ID: 30961401
[No Abstract] [Full Text] [Related]
54. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.
Rossi D; Volanti P; Brambilla L; Colletti T; Spataro R; La Bella V
J Neurol; 2018 Mar; 265(3):510-521. PubMed ID: 29322259
[TBL] [Abstract][Full Text] [Related]
55. Flecainide in Amyotrophic Lateral Sclerosis as a Neuroprotective Strategy (FANS): A Randomized Placebo-Controlled Trial.
Park SB; Vucic S; Cheah BC; Lin CS; Kirby A; Mann KP; Zoing MC; Winhammar J; Kiernan MC
EBioMedicine; 2015 Dec; 2(12):1916-22. PubMed ID: 26844270
[TBL] [Abstract][Full Text] [Related]
56. Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial.
Verstraete E; Veldink JH; Huisman MH; Draak T; Uijtendaal EV; van der Kooi AJ; Schelhaas HJ; de Visser M; van der Tweel I; van den Berg LH
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):557-64. PubMed ID: 22378918
[TBL] [Abstract][Full Text] [Related]
57. Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis.
Agnello L; Colletti T; Lo Sasso B; Vidali M; Spataro R; Gambino CM; Giglio RV; Piccoli T; Bivona G; La Bella V; Ciaccio M
Eur J Neurol; 2021 Jun; 28(6):1868-1875. PubMed ID: 33638255
[TBL] [Abstract][Full Text] [Related]
58. Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosis.
Hwang CS; Liu GT; Chang MD; Liao IL; Chang HT
Neurobiol Dis; 2013 Oct; 58():13-8. PubMed ID: 23639787
[TBL] [Abstract][Full Text] [Related]
59. The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial.
Dalla Bella E; Bersano E; Antonini G; Borghero G; Capasso M; Caponnetto C; Chiò A; Corbo M; Filosto M; Giannini F; Spataro R; Lunetta C; Mandrioli J; Messina S; Monsurrò MR; Mora G; Riva N; Rizzi R; Siciliano G; Silani V; Simone I; Sorarù G; Tugnoli V; Verriello L; Volanti P; Furlan R; Nolan JM; Abgueguen E; Tramacere I; Lauria G
Brain; 2021 Oct; 144(9):2635-2647. PubMed ID: 33905493
[TBL] [Abstract][Full Text] [Related]
60. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis.
Verde F; Steinacker P; Weishaupt JH; Kassubek J; Oeckl P; Halbgebauer S; Tumani H; von Arnim CAF; Dorst J; Feneberg E; Mayer B; Müller HP; Gorges M; Rosenbohm A; Volk AE; Silani V; Ludolph AC; Otto M
J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):157-164. PubMed ID: 30309882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
